This is implied that COVID-19-induced lung-destructive inflammation might erupt rather via aggravation of ADAM-17-mediated release of mACE2 and TNF-α which results in the dysregulation of local RAS in favor of Ang II/AT1R axis and promoting inflammatory responses. The gene discussed is ADAM17; the disease is COVID-19.